The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Development of Approaches to Improve Cell Survival in Myoblast Transfer Therapy
Open accessAbstract
Myoblast transplantation has been extensively studied as a gene complementation approach for genetic diseases such as Duchenne Muscular Dystrophy. This approach has been found capable of delivering dystrophin, the product missing in Duchenne Muscular Dystrophy muscle, and leading to an increase of strength in the dystrophic muscle. This approach, however, has been hindered by numerous limitations, including immunological problems, and low spread and poor survival of the injected myoblasts. We have investigated whether antiinflammatory treatment and use of different populations of skeletal muscle–derived cells may circumvent the poor survival of the injected myoblasts after implantation. We have observed that different populations of muscle-derived cells can be isolated from skeletal muscle based on their desmin immunoreactivity and differentiation capacity. Moreover, these cells acted differently when injected into muscle: 95% of the injected cells in some populations died within 48 h, while others richer in desmin-positive cells survived entirely. Since pure myoblasts obtained from isolated myofibers and myoblast cell lines also displayed a poor survival rate of the injected cells, we have concluded that the differential survival of the populations of muscle-derived cells is not only attributable to their content in desmin-positive cells. We have observed that the origin of the myogenic cells may influence their survival in the injected muscle. Finally, we have observed that myoblasts genetically engineered to express an inhibitor of the inflammatory cytokine, IL-1, can improve the survival rate of the injected myoblasts. Our results suggest that selection of specific muscle-derived cell populations or the control of inflammation can be used as an approach to improve cell survival after both myoblast transplantation and the myoblast-mediated ex vivo gene transfer approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Ashburner, M. (1989) · Cold Spring Harbor Laboratory eBooks · Cited by 6,756
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
X chromosome-linked muscular dystrophy (mdx) in the mouse
Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1189 · Cited by 1,765 · cited 1×
“The mdx mouse, an animal model for DMD, also lacks dystrophin and DAPs in skeletal muscle fibers (Bulfield et al., 1984; Hoffman et al., 1987; Sincinsky et al., 1989).”
BackgroundCellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
Ibraghimov-Beskrovnaya, O., Ervasti, J. M., Leveille, C. J., Slaughter, C. A., Sernett, S. W., & Campbell, K. P. (1992) · Nature · doi:10.1038/355696a0 · Cited by 1,410
Membrane organization of the dystrophin-glycoprotein complex
Ervasti, J. M., & Campbell, K. P. (1991) · Cell · doi:10.1016/0092-8674(91)90035-w · Cited by 1,329
The Molecular Basis of Muscular Dystrophy in the mdx Mouse: a Point Mutation
Sicinski, P., Geng, Y., Ryder-Cook, A. S., Barnard, E. A., Darlison, M. G., & Barnard, P. J. (1989) · Science · doi:10.1126/science.2662404 · Cited by 1,276
Rando, T. A., & Blau, H. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.6.1275 · Cited by 936
Xiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 912
Cited by
Satellite Cells and the Muscle Stem Cell Niche
Yin, H., Price, F., & Rudnicki, M. A. (2013) · Physiological Reviews · doi:10.1152/physrev.00043.2011 · Cited by 2,166
“A series of studies have demonstrated that a distinct cell population, termed muscle-derived stem cells (MDSCs), can be isolated from skeletal muscles based on their weak adhesion characteristics and long-term proliferation behaviors in culture (247, 294, 421, 422).”
BackgroundAsymmetric self-renewal and commitment of satellite stem cells in muscle
Kuang, S., Kuroda, K., Le Grand, F., & Rudnicki, M. A. (2007) · Cell · doi:10.1016/j.cell.2007.03.044 · Cited by 1,449
Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle
Blake, D. J., Weir, A., Newey, S. E., & Davies, K. E. (2002) · Physiological Reviews · doi:10.1152/physrev.00028.2001 · Cited by 1,242
Expression of Cd34 and Myf5 Defines the Majority of Quiescent Adult Skeletal Muscle Satellite Cells
Beauchamp, J. R., Heslop, L., Yu, D. S. W., Tajbakhsh, S., Kelly, R. G., Wernig, A., Buckingham, M. E., Partridge, T. A., & Zammit, P. S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1221 · Cited by 916
Identification of a novel population of muscle stem cells in mice
Qu-Petersen, Z., Deasy, B., Jankowski, R., Ikezawa, M., Cummins, J., Pruchnic, R., Mytinger, J., Cao, B., Gates, C., Wernig, A., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108150 · Cited by 846
Self-citationClonal Isolation of Muscle-Derived Cells Capable of Enhancing Muscle Regeneration and Bone Healing
Lee, J. Y., Qu-Petersen, Z., Cao, B., Kimura, S., Jankowski, R., Cummins, J., Usas, A., Gates, C., Robbins, P., Wernig, A., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.5.1085 · Cited by 642
Self-citationBeauchamp, J. R., Morgan, J. E., Pagel, C. N., & Partridge, T. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.6.1113 · Cited by 514
Ye, L., Chang, Y.-H., Xiong, Q., Zhang, P., Zhang, L., Somasundaram, P., Lepley, M., Swingen, C., Su, L., Wendel, J. S., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.11.009 · Cited by 454
Functional skeletal muscle regeneration from differentiating embryonic stem cells
Darabi, R., Gehlbach, K., Bachoo, R. M., Kamath, S., Osawa, M., Kamm, K. E., Kyba, M., & Perlingeiro, R. C. R. (2008) · Nature Medicine · doi:10.1038/nm1705 · Cited by 359
Gharaibeh, B., Lu, A., Tebbets, J., Zheng, B., Feduska, J., Crisan, M., Péault, B., Cummins, J., & Huard, J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.142 · Cited by 335
Self-citationJankowski, R. J., Deasy, B. M., & Huard, J. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301719 · Cited by 331
Self-citationEvidence for a myogenic stem cell that is exhausted in dystrophic muscle
Heslop, L., Morgan, J. E., & Partridge, T. A. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.12.2299 · Cited by 297
Use of differentiated pluripotent stem cells in replacement therapy for treating disease
Fox, I. J., Daley, G. Q., Goldman, S. A., Huard, J., Kamp, T. J., & Trucco, M. (2014) · Science · doi:10.1126/science.1247391 · Cited by 291
Self-citationZhang, D., Fan, G.-C., Zhou, X., Zhao, T., Pasha, Z., Xu, M., Zhu, Y., Ashraf, M., & Wang, Y. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.11.010 · Cited by 278
Osteoprogenitor cells within skeletal muscle
Bosch, P., Musgrave, D. S., Lee, J. Y., Cummins, J., Shuler, F., Ghivizzani, S. C., Evans, C., Robbins, P. D., & Huard, J. (2000) · Journal of Orthopaedic Research · doi:10.1002/jor.1100180613 · Cited by 271
Self-citationMuscle stem cells differentiate into haematopoietic lineages but retain myogenic potential
Cao, B., Zheng, B., Jankowski, R. J., Kimura, S., Ikezawa, M., Deasy, B., Cummins, J., Epperly, M., Qu-Petersen, Z., & Huard, J. (2003) · Nature Cell Biology · doi:10.1038/ncb1008 · Cited by 263
Self-citationIntraarterial Injection of Muscle-Derived Cd34+Sca-1+ Stem Cells Restores Dystrophin in mdx Mice
Torrente, Y., Tremblay, J.-P., Pisati, F., Belicchi, M., Rossi, B., Sironi, M., Fortunato, F., El Fahime, M., D'Angelo, M. G., Caron, N. J., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.2.335 · Cited by 262
The Use of an Antifibrosis Agent to Improve Muscle Recovery after Laceration
Fukushima, K., Badlani, N., Usas, A., Riano, F., Fu, F. H., & Huard, J. (2001) · The American Journal of Sports Medicine · doi:10.1177/03635465010290040201 · Cited by 260
Self-citationThe skeletal muscle satellite cell: stem cell or son of stem cell?
Zammit, P. S., & Beauchamp, J. R. (2001) · Differentiation · doi:10.1046/j.1432-0436.2001.680407.x · Cited by 259
Generation of different fates from multipotent muscle stem cells
Wada, M. R., Inagawa-Ogashiwa, M., Shimizu, S., Yasumoto, S., & Hashimoto, N. (2002) · Development · doi:10.1242/dev.129.12.2987 · Cited by 258
Deasy, B. M., Lu, A., Tebbets, J. C., Feduska, J. M., Schugar, R. C., Pollett, J. B., Sun, B., Urish, K. L., Gharaibeh, B. M., Cao, B., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612094 · Cited by 251
Self-citationProspective Isolation of Skeletal Muscle Stem Cells with a Pax7 Reporter
Bosnakovski, D., Xu, Z., Li, W., Thet, S., Cleaver, O., Perlingeiro, R. C. R., & Kyba, M. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1017 · Cited by 187
The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy
Mouly, V., Aamiri, A., Bigot, A., Cooper, R. N., Di Donna, S., Furling, D., Gidaro, T., Jacquemin, V., Mamchaoui, K., Negroni, E., et al. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2005.01417.x · Cited by 106
Gene Delivery Using Herpes Simplex Virus Vectors
Burton, E. A., Fink, D. J., & Glorioso, J. C. (2002) · DNA and Cell Biology · doi:10.1089/104454902762053864 · Cited by 92
Metadata
- Authors
- Qu, Z., Balkir, L., van Deutekom, J. C. T., Robbins, P. D., Pruchnic, R., & Huard, J.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 1998-09-07
- Volume
- 142
- Issue
- 5
- Pages
- 1257-1267
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W1968814074
- Cited by
- 462
- References
- 67
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.